UK markets open in 16 minutes

Nanobiotix S.A. (NBTX)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
7.11-0.12 (-1.66%)
At close: 04:00PM EDT
7.10 -0.01 (-0.14%)
After hours: 04:23PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 333.07M
Enterprise value 306.23M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.03
Price/book (mrq)65.02
Enterprise value/revenue 9.38
Enterprise value/EBITDA -2.45

Trading information

Stock price history

Beta (5Y monthly) 1.26
52-week change 342.48%
S&P500 52-week change 329.31%
52-week high 311.00
52-week low 34.55
50-day moving average 36.29
200-day moving average 37.07

Share statistics

Avg vol (3-month) 329.9k
Avg vol (10-day) 35.44k
Shares outstanding 547.11M
Implied shares outstanding 647.33M
Float 822.79M
% held by insiders 10.00%
% held by institutions 119.76%
Shares short (30 Apr 2024) 455.69k
Short ratio (30 Apr 2024) 40.67
Short % of float (30 Apr 2024) 4N/A
Short % of shares outstanding (30 Apr 2024) 40.12%
Shares short (prior month 28 Mar 2024) 450.27k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -109.64%
Operating margin (ttm)3.46%

Management effectiveness

Return on assets (ttm)-19.72%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)36.21M
Revenue per share (ttm)0.98
Quarterly revenue growth (yoy)854.90%
Gross profit (ttm)N/A
EBITDA -23.69M
Net income avi to common (ttm)-39.7M
Diluted EPS (ttm)-1.17
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)75.28M
Total cash per share (mrq)1.6
Total debt (mrq)50.56M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.75
Book value per share (mrq)-0.04

Cash flow statement

Operating cash flow (ttm)-12.48M
Levered free cash flow (ttm)-5.27M